Development of individualized anticoagulation method in atrial fibrillation patients with end stage renal disease
Not Applicable
- Conditions
- Diseases of the circulatory system
- Registration Number
- KCT0006397
- Lead Sponsor
- Yonsei University Wonju College of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
End stage renal disease patients with receiving renal replacement therapy
with atrial fibrillation
Exclusion Criteria
patients under 18 years old or over 90 years old
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method all cause mortality
- Secondary Outcome Measures
Name Time Method major organ bleeding